JLE

European Journal of Dermatology

MENU

Examination of skin lesions for cancer: Which clinical decision aids and tools are available in general practice? Volume 24, numéro 3, May-June 2014

Illustrations


  • Figure 1

Tableaux

Auteurs
1 Department of General Practice,
2 Department of Dermatology,
University Medical Center Groningen,
University of Groningen,
PO Box 196
9700 AD Groningen,
the Netherlands
* Reprints

Background While skin cancer incidence is rising throughout Europe, general practitioners (GP) feel unsure about their ability to diagnose skin malignancies. Objectives To evaluate whether the GP has sufficient validated clinical decision aids and tools for the examination of potentially malignant skin lesions. Methods We conducted a review searching Medline and the Cochrane Library. In addition, reference lists and personal archives were examined. Outcome measures were sensitivity and specificity but also the advantages and disadvantages of different clinical decision aids and tools. Results No clinical decision aids or tools for the examination of non-pigmented lesions are available. Clinical decision aids and tools for the examination of pigmented lesions have mostly been studied in secondary care and, in primary care, randomised clinical trials comparing the additional value of a clinical decision aid or tools to care are scarce. Conclusion Sufficiently validated clinical decision aids and tools for the examination of potentially malignant skin lesions are lacking in general practice. The clinical decision aids and tools available in primary care need to be studied.